137 related articles for article (PubMed ID: 37812290)
1. Intraoperative or postoperative stereotactic radiotherapy for brain metastases: time to systemic treatment onset and other patient-relevant outcomes.
Dejonckheere CS; Layer JP; Hamed M; Layer K; Glasmacher A; Friker LL; Potthoff AL; Zeyen T; Scafa D; Koch D; Garbe S; Holz JA; Kugel F; Grimmer M; Schmeel FC; Gielen GH; Forstbauer H; Vatter H; Herrlinger U; Giordano FA; Schneider M; Schmeel LC; Sarria GR
J Neurooncol; 2023 Sep; 164(3):683-691. PubMed ID: 37812290
[TBL] [Abstract][Full Text] [Related]
2. Outcome assessment of intraoperative radiotherapy for brain metastases: results of a prospective observational study with comparative matched-pair analysis.
Layer JP; Hamed M; Potthoff AL; Dejonckheere CS; Layer K; Sarria GR; Scafa D; Koch D; Köksal M; Kugel F; Grimmer M; Holz JA; Zeyen T; Friker LL; Borger V; Schmeel FC; Weller J; Hölzel M; Schäfer N; Garbe S; Forstbauer H; Giordano FA; Herrlinger U; Vatter H; Schneider M; Schmeel LC
J Neurooncol; 2023 Aug; 164(1):107-116. PubMed ID: 37477822
[TBL] [Abstract][Full Text] [Related]
3. Intraoperative radiotherapy (IORT) for surgically resected brain metastases: outcome analysis of an international cooperative study.
Cifarelli CP; Brehmer S; Vargo JA; Hack JD; Kahl KH; Sarria-Vargas G; Giordano FA
J Neurooncol; 2019 Nov; 145(2):391-397. PubMed ID: 31654248
[TBL] [Abstract][Full Text] [Related]
4. Early motor function after local treatment of brain metastases in the motor cortex region with stereotactic radiotherapy/radiosurgery or microsurgical resection: a retrospective study of two consecutive cohorts.
Pintea B; Baumert B; Kinfe TM; Gousias K; Parpaley Y; Boström JP
Radiat Oncol; 2017 Nov; 12(1):177. PubMed ID: 29132382
[TBL] [Abstract][Full Text] [Related]
5. Intraoperative radiotherapy after resection of brain metastases located in the posterior fossa. Analysis of postoperative morbidity and mortality in a single center cohort.
Krauss P; Kahl KH; Bonk MN; Wolfert C; Sommer B; Stueben G; Shiban E
J Clin Neurosci; 2023 Dec; 118():1-6. PubMed ID: 37832264
[TBL] [Abstract][Full Text] [Related]
6. Intraoperative radiotherapy to treat newly diagnosed solitary brain metastasis: initial experience and long-term outcomes.
Weil RJ; Mavinkurve GG; Chao ST; Vogelbaum MA; Suh JH; Kolar M; Toms SA
J Neurosurg; 2015 Apr; 122(4):825-32. PubMed ID: 25614945
[TBL] [Abstract][Full Text] [Related]
7. Acute toxicities and cumulative dose to the brain of repeated sessions of stereotactic radiotherapy (SRT) for brain metastases: a retrospective study of 184 patients.
Kuntz L; Le Fèvre C; Jarnet D; Keller A; Meyer P; Thiery A; Cebula H; Noel G; Antoni D
Radiat Oncol; 2023 Jan; 18(1):7. PubMed ID: 36627646
[TBL] [Abstract][Full Text] [Related]
8. Hypofractionated stereotactic radiotherapy (HFSRT) versus single fraction stereotactic radiosurgery (SRS) to the resection cavity of brain metastases after surgical resection (SATURNUS): study protocol for a randomized phase III trial.
Waltenberger M; Bernhardt D; Diehl C; Gempt J; Meyer B; Straube C; Wiestler B; Wilkens JJ; Zimmer C; Combs SE
BMC Cancer; 2023 Jul; 23(1):709. PubMed ID: 37516835
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of dose escalation using intraoperative radiotherapy following resection of large brain metastases compared to post-operative stereotactic radiosurgery.
Vargo JA; Sparks KM; Singh R; Jacobson GM; Hack JD; Cifarelli CP
J Neurooncol; 2018 Nov; 140(2):413-420. PubMed ID: 30094718
[TBL] [Abstract][Full Text] [Related]
10. Dose homogeneity analysis of adjuvant radiation treatment in surgically resected brain metastases: Comparison of IORT, SRS, and IMRT indices.
Dahshan BA; Weir JS; Bice RP; Renz P; Cifarelli DT; Poplawski L; Hack J; Vargo JA; Cifarelli CP
Brachytherapy; 2021; 20(2):426-432. PubMed ID: 33454200
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Stereotactic Radiotherapy of the Resection Cavity After Surgery of Brain Metastases Compared to Postoperative Whole-Brain Radiotherapy (ESTRON)-A Single-Center Prospective Randomized Trial.
El Shafie RA; Paul A; Bernhardt D; Hauswald H; Welzel T; Sprave T; Hommertgen A; Krisam J; Schmitt D; Klüter S; Schubert K; Klose C; Kieser M; Debus J; Rieken S
Neurosurgery; 2018 Sep; 83(3):566-573. PubMed ID: 29528419
[TBL] [Abstract][Full Text] [Related]
12. Multicentric Assessment of Safety and Efficacy of Combinatorial Adjuvant Brain Metastasis Treatment by Intraoperative Radiation Therapy and Immunotherapy.
Layer JP; Shiban E; Brehmer S; Diehl CD; de Castro DG; Hamed M; Dejonckheere CS; Cifarelli DT; Friker LL; Herrlinger U; Hölzel M; Vatter H; Schneider M; Combs SE; Schmeel LC; Cifarelli CP; Giordano FA; Sarria GR; Kahl KH
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1552-1562. PubMed ID: 38199383
[TBL] [Abstract][Full Text] [Related]
13. Impact of regular magnetic resonance imaging follow-up after stereotactic radiotherapy to the surgical cavity in patients with one to three brain metastases.
Bachmann N; Leiser D; Ermis E; Vulcu S; Schucht P; Raabe A; Aebersold DM; Herrmann E
Radiat Oncol; 2019 Mar; 14(1):45. PubMed ID: 30871597
[TBL] [Abstract][Full Text] [Related]
14. Intracranial intraoperative radiotherapy (IORT): evaluation of electrocorticography and peri-operative seizure risk.
Cifarelli CP; Vargo JA; Sener U; Cifarelli DT; Scoville D; Dabir A
J Neurooncol; 2023 Sep; 164(2):423-430. PubMed ID: 37668944
[TBL] [Abstract][Full Text] [Related]
15. Resection followed by stereotactic radiosurgery to resection cavity for intracranial metastases.
Do L; Pezner R; Radany E; Liu A; Staud C; Badie B
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):486-91. PubMed ID: 18922650
[TBL] [Abstract][Full Text] [Related]
16. Changes in the characteristics of patients treated for brain metastases with repeat stereotactic radiotherapy (SRT): a retrospective study of 184 patients.
Kuntz L; Le Fèvre C; Jarnet D; Keller A; Meyer P; Thiery A; Cebula H; Noel G; Antoni D
Radiat Oncol; 2023 Jan; 18(1):21. PubMed ID: 36717863
[TBL] [Abstract][Full Text] [Related]
17. A phase III, multicenter, randomized controlled trial of preoperative versus postoperative stereotactic radiosurgery for patients with surgically resectable brain metastases.
Das S; Faruqi S; Nordal R; Starreveld Y; Kelly J; Bowden G; Amanie J; Fairchild A; Lim G; Loewen S; Rowe L; Wallace C; Ghosh S; Patel S
BMC Cancer; 2022 Dec; 22(1):1368. PubMed ID: 36585629
[TBL] [Abstract][Full Text] [Related]
18. Surgical bed stereotactic radiotherapy of brain metastases: Clinical outcome and predictors of local and distant brain failure.
Mousli A; Bihin B; Gustin T; Koerts G; Mouchamps M; Daisne JF
Cancer Radiother; 2020 Jul; 24(4):298-305. PubMed ID: 32173270
[TBL] [Abstract][Full Text] [Related]
19. Surgery versus stereotactic radiotherapy for people with single or solitary brain metastasis.
Fuentes R; Osorio D; Expósito Hernandez J; Simancas-Racines D; Martinez-Zapata MJ; Bonfill Cosp X
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012086. PubMed ID: 30125049
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of linac-based fractionated stereotactic radiotherapy and stereotactic radiosurgery for patients with up to ten brain metastases.
Hirata M; Yasui K; Oota N; Ogawa H; Onoe T; Maki S; Ito Y; Hayashi K; Asakura H; Murayama S; Mitsuya K; Deguchi S; Nakamura K; Hayashi N; Nishimura T; Harada H
Radiat Oncol; 2022 Dec; 17(1):213. PubMed ID: 36578021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
